On ECHEMI
Home > Drugs > Amibutrol Tablets

Amibutrol Tablets

Function and Efficacy

Ambroxol tablets are a compound preparation composed of ambroxol hydrochloride and clenbuterol hydrochloride. Ambroxol hydrochloride is a mucolytic agent that can increase the secretion of respiratory mucosal serous glands, reduce mucus gland secretion, reduce sputum viscosity, promote the secretion of pulmonary surfactant, increase bronchial ciliary movement, and make sputum easier to cough up. Clenbuterol hydrochloride is a selective β-receptor agonist that relaxes bronchial smooth muscles, enhances ciliary movement, dissolves mucus, and promotes sputum discharge.

Ingredients

This product is a compound preparation, its components are ambroxol hydrochloride and clenbuterol hydrochloride.

Name Description Content CAS NO. Manufacturer
Ambroxol hydrochlorideIngredients

Mucolytics can increase the secretion of respiratory mucosal serous glands, reduce mucous gland secretion, reduce sputum viscosity, promote the secretion of pulmonary surfactant, increase bronchial ciliary movement, and make sputum easier to cough up.

More
23828-92-4 38
Clenbuterol hydrochlorideIngredients

Selective beta-receptor agonists relax bronchial smooth muscles, enhance ciliary movement, dissolve mucus, and promote sputum discharge

More
21898-19-1 14

Appearance

This product is yellow round tablet.

Indication

Used to treat cough, thick sputum, difficulty in expectoration, wheezing, etc. caused by acute and chronic respiratory diseases (such as acute and chronic bronchitis, bronchial asthma, emphysema, etc.).

Usage and Dosage

Children over 12 years old and adults: Oral administration, 1 tablet at a time, 2 times a day; for patients with severe dyspnea, take orally, 1 tablet at a time, 3 times a day for the first 2 to 3 days.

Adverse Reactions

This product is well tolerated, with occasional mild gastrointestinal reactions and rashes. Some patients occasionally experience mild dry mouth, hand tremors, dizziness, palpitations, etc., which disappear upon discontinuation of the drug. 1) Mental and nervous system: Occasionally headaches, hand tremors, drowsiness, restlessness, dizziness, insomnia, excitement, numbness of the limbs, etc. 2) Circulatory system: Occasionally palpitations, tachycardia, increased blood pressure, arrhythmia, etc. 3) Allergies: Occasionally allergic rashes, and in some patients with specific constitutions, systemic allergies may occur, manifested as itching, bronchospasm, hypotension, collapse, etc., and the drug should be discontinued at this time. 4) Others: Occasionally increased ALT, AST, fatigue, gastrointestinal discomfort, etc.

Precautions

1. It is contraindicated for patients with hypertrophic cardiomyopathy. 2. It is contraindicated for patients who are allergic to this product.

Special Population Medication

Precautions for children: This product is not suitable for children under 12 years old. Precautions for pregnancy and lactation: According to reports, in animal experiments (rats), after using this product in the late pregnancy, the contraction of uterine smooth muscle was inhibited, which caused delayed delivery and placental pain. The safety of this product to the fetus is still unclear, so pregnant women, especially those within 3 months of pregnancy, should use it with caution. This product can be excreted through breast milk, so lactating women should use it with caution. Precautions for the elderly: Due to the low physiological function of the elderly, attention should be paid to reducing the dosage.

Drug Interactions

1. Studies have shown that ambroxol can increase the concentration of antibiotics in the respiratory tract. 2. It can cause arrhythmia when used in combination with catecholamines such as epinephrine and isoproterenol, so it should not be used in combination. 3. Patients who are taking MAO inhibitors or tricyclic antidepressants should pay special attention to the effect of this product on the vascular system after taking this product. 4. It should not be used in combination with non-selective beta-receptor blocking drugs such as propranolol. 5. Patients who are taking a large amount of other sympathetic stimulants should be careful when taking this product.

Storage

Keep away from light and store in sealed container.

Packaging Specification

This product is a compound preparation, each tablet contains 30 mg of ambroxol hydrochloride and 0.02 mg of clenbuterol hydrochloride.

Validity Period

36 months

Manufacturer

Beijing Hanmi Pharmaceutical Co., Ltd.

  • Founded in:

    1996-03-27
  • Address:

    No. 10, Tianzhu West Road, Area A, Tianzhu Airport Industrial Zone, Shunyi District, Beijing
  • Tax NO.:

    91110113600048921K
  • Registered Funds:

    630 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.